Genetic factors determining cutaneous basal cell carcinoma phenotype

2001 ◽  
Vol 36 (5) ◽  
pp. 559-563 ◽  
Author(s):  
Sudarshan Ramachandran ◽  
Anthony A. Fryer ◽  
Richard C. Strange
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Genetic Factors

scholarly journals Genetic factors underlying basal cell carcinoma risk: a narrative review

2021 ◽  
Vol 0 ◽  
pp. 0-0
Author(s):  
Sitong Ju ◽  
Wanlin Fan ◽  
Alexander C. Rokohl ◽  
Yongwei Guo ◽  
Vinodh Kakkassery ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Genetic Factors ◽  
Narrative Review ◽  
Carcinoma Risk

scholarly journals POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors

2011 ◽  
Vol 63 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Cosmeri Rizzato ◽  
Dominique Scherer ◽  
Peter Rudnai ◽  
Eugen Gurzau ◽  
Kvetoslava Koppova ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Genetic Variability ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Genetic Factors

scholarly journals Basal Cell Carcinoma: A Comprehensive Review

2020 ◽  
Vol 21 (15) ◽  
pp. 5572 ◽  
Author(s):  
Emi Dika ◽  
Federica Scarfì ◽  
Manuela Ferracin ◽  
Elisabetta Broseghini ◽  
Emanuela Marcelli ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Genetic Factors ◽  
Common Type ◽  
Complex Interaction ◽  
Mechanisms Of Resistance ◽  
Molecular Features ◽  
Systemic Treatments ◽  
Systemic Therapies

Basal cell carcinoma (BCC) is the most common type of carcinoma worldwide. BCC development is the result of a complex interaction between environmental, phenotypic and genetic factors. However, despite the progress in the field, BCC biology and mechanisms of resistance against systemic treatments have been poorly investigated. The aim of the present review is to provide a revision of BCC histological and molecular features, including microRNA (miRNA) dysregulation, with a specific focus on the molecular basis of BCC systemic therapies. Papers from the last ten years regarding BCC genetic and phenotypic alterations, as well as the mechanism of resistance against hedgehog pathway inhibitors vismodegib and sonidegib were included. The involvement of miRNAs in BCC resistance to systemic therapies is emerging as a new field of knowledge.

Ultrastructure of Mouse Basal Cell Carcinoma Exhibiting Sebaceous Differentiation

1980 ◽  
Vol 38 ◽  
pp. 738-739
Author(s):  
Victoria L. Wade ◽  
Winslow G. Sheldon ◽  
James W. Townsend ◽  
William Allaben
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Topical Application ◽  
Basal Cell ◽  
Sebaceous Gland ◽  
Rats And Mice ◽  
Mixed Tumors

Sebaceous gland tumors and other tumors exhibiting sebaceous differentiation have been described in humans (1,2,3). Tumors of the sebaceous gland can be induced in rats and mice following topical application of carcinogens (4), but spontaneous mixed tumors of basal cell origin rarely occur in mice.

Basal cell carcinoma of the nail bed in a Korean woman

2000 ◽  
Vol 39 (5) ◽  
pp. 397-398 ◽  
Author(s):  
Hyoung-Joo Kim ◽  
Youn-Soo Kim ◽  
Ki-Beom Suhr ◽  
Tae-Young Yoon ◽  
Jeung-Hoon Lee ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Korean Woman ◽  
Nail Bed

Basal cell carcinoma of the nipple

1978 ◽  
Vol 114 (12) ◽  
pp. 1845-1845 ◽  
Author(s):  
G. P. Lupton
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell
Sign in / Sign up

Export Citation Format

Share Document